Skip to main content
Figure 2 | Respiratory Research

Figure 2

From: Improving inhaler adherence in patients with Chronic Obstructive Pulmonary Disease: a cost-effectiveness analysis

Figure 2

Summary of 1-year effects on costs. Usual care: Medication costs (850), Pharmacy fee (0), Exacerbation costs (1598), Total costs (2448); Intervention: Medication costs (934), Pharmacy fee (77), Exacerbation costs (1210), Total costs (2221); Difference (95% CI): Medication costs (84; 44-129), Pharmacy fee (77; 55-104), Exacerbation costs (-388; -225 - -560), Total costs (-227; -58 - -403).

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us